900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
Product containing precisely mesna 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely mesna 400 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely mesna 600 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metformin hydrochloride 500 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methadone hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methadone hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methadone hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methadone hydrochloride 2 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methadone hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methadone hydrochloride 5 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methotrexate (as methotrexate sodium) 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methotrexate (as methotrexate sodium) 2.5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methotrexate (as methotrexate sodium) 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methotrexate (as methotrexate sodium) 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methotrexate (as methotrexate sodium) 25 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methoxy polyethylene glycol-epoetin beta 166.667 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methoxy polyethylene glycol-epoetin beta 250 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methoxy polyethylene glycol-epoetin beta 500 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methoxy polyethylene glycol-epoetin beta 666.667 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methoxy polyethylene glycol-epoetin beta 833.333 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methyldopa 250 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methyldopa 250 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methylprednisolone (as methylprednisolone sodium succinate) 40 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely methylthioninium chloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metoclopramide (as metoclopramide hydrochloride) 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metoclopramide hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metoclopramide hydrochloride 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metoprolol tartrate 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metoprolol tartrate 25 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metoprolol tartrate 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metronidazole (as metronidazole benzoate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metronidazole 1 gram/1 each conventional release rectal suppository (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metronidazole 200 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metronidazole 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metronidazole 500 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely metronidazole 500 milligram/1 each conventional release rectal suppository (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release cutaneous cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely midazolam (as midazolam hydrochloride) 1 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely midazolam (as midazolam hydrochloride) 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely midazolam (as midazolam hydrochloride) 2 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely midazolam (as midazolam hydrochloride) 5 milligram/1 milliliter conventional release oromucosal solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely midazolam (as midazolam maleate) 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely midazolam (as midazolam maleate) 15 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely midazolam (as midazolam maleate) 7.5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely mifepristone 200 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely miltefosine 10 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely miltefosine 50 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely misoprostol 200 microgram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely misoprostol 25 microgram/1 each conventional release vaginal tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 10 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 10 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 10 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 100 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 100 milligram/1 sachet prolonged-release oral granules (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 15 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral solution (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 20 milligram/1 sachet prolonged-release oral granules (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 200 milligram/1 sachet prolonged-release oral granules (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 30 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 30 milligram/1 sachet prolonged-release oral granules (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 60 milligram/1 each prolonged-release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely morphine sulfate 60 milligram/1 sachet prolonged-release oral granules (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 400 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 gram conventional release cutaneous cream (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely mupirocin 20 milligram/1 gram conventional release cutaneous ointment (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nadroparin calcium 19000 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nadroparin calcium 9500 unit/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely naloxone hydrochloride 400 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely neostigmine bromide 15 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely neostigmine methylsulfate 2.5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely neostigmine methylsulfate 500 microgram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nevirapine 10 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nevirapine 200 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nevirapine 50 milligram/1 each tablet for conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely niclosamide 500 milligram/1 each conventional release chewable tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nicotinamide 50 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nicotine (as nicotine polacrilex) 2 milligram/1 chewing gum prolonged-release oral gum (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nicotine (as nicotine polacrilex) 4 milligram/1 chewing gum prolonged-release oral gum (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nicotine 291.667 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nicotine 312.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nicotine 583.333 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nicotine 625 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nicotine 875 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nicotine 937.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nifedipine 10 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nifurtimox 120 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nifurtimox 30 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nilotinib (as nilotinib hydrochloride) 150 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nilotinib (as nilotinib hydrochloride) 200 milligram/1 each conventional release oral capsule (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nitrofurantoin 100 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nitrofurantoin 5 milligram/1 milliliter conventional release oral suspension (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nitrous oxide 1 milliliter/1 milliliter conventional release gas for inhalation (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely nivolumab 10 milligram/1 milliliter conventional release solution for infusion (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely norethisterone 350 microgram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely norethisterone 5 milligram/1 each conventional release oral tablet (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely norethisterone enantate 200 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)
Product containing precisely normal human immunoglobulin 100 milligram/1 milliliter conventional release solution for injection (clinical drug)	Preferred (foundation metadata concept)

Start Previous Page 411 of 579 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	IPS terminology module (core metadata concept)